Core Viewpoint - China Resources Medical (01515) issued a profit warning, anticipating a profit decline of approximately 20% to 25% for the six months ending June 30, 2025, compared to the same period in 2024, with a more significant decline of about 55% to 60% when excluding one-time management fees and compensation related to the Yanhua IOT agreement [1][1][1] Group 1 - The company's stock opened lower by 7% and is currently trading at HKD 4.12, with a trading volume of HKD 4.1591 million [1][1] - The anticipated profit decline is primarily attributed to a decrease in average medical expenses under the medical insurance system, leading to reduced operating profits for member medical institutions [1][1][1] - The company is gradually exiting the IOT (Investment-Operation-Transfer) business, resulting in a decline in profit contributions from this segment [1][1][1] Group 2 - For the second half of 2025, the company plans to actively improve its revenue structure, enhance management precision, control operational costs, and increase operational efficiency [1][1][1]
华润医疗盈警后低开7% 预计中期股东应占利润同比下降约20%至25%